Le Lézard
Classified in: Health
Subject: TDS

Venclose to Participate in 2020 Piper Sandler Healthcare Conference

SAN JOSE, Calif., Nov. 30, 2020 /PRNewswire/ -- Venclose Inc., a privately-held medical device corporation focused on innovative advancements for the minimally invasive treatment of chronic venous insufficiency, a major underlying cause of varicose veins, today announced that Jerry Gibson, Venclose Chairman and CEO, will participate in the 32nd Annual Piper Sandler Healthcare Conference taking place virtually November 30 - December 3, 2020.

"Venclose is honored to be one of the 40 private companies selected to participate in this year's conference," commented Mr. Gibson. "We are pleased to share the company's commercial progress, a direct reflection of the quality of products in the Venclose portfolio and the hard work of its valued employees. We look forward to highlighting our exciting future plans and upcoming product launches."

The Venclose Corporate Overview presentation can be viewed in the Newsroom section of the Venclose website: https://venclose.com/news/.

About Venclose, Inc.

Venclose is a privately held, commercial-stage Silicon Valley medical technology company developing next-generation solutions for the treatment of venous reflux disease, also known as chronic venous insufficiency (CVI). CVI is a progressive medical condition affecting more than 40 million adults in the United States alone. The VENCLOSE RF Ablation System offers physicians more versatility than earlier generation endovenous radiofrequency ablation technologies and is commercially available in the United States and Europe. For more information, visit www.venclose.com.

Media contact:                                                              Investor Relations
Name: Jon Kitahara                                                       Name: Peter Osborne
Venclose, Communications                                           Venclose, Chief Financial Officer
Phone: 408 460 5572                                                    Phone 408 888 9460
Email: Jkitahara@venclose.com                                   Email: posborne@venclose.com



SOURCE Venclose, Inc.

These press releases may also interest you

at 22:45
Based in Willowbrook, Illinois, Russell Health, a national marketer and distributor of specialty medical products and services, has recently been issued company trademark registrations from the United States Patent and Trademark Office.  Russell...

at 22:30
Casio Computer Co., Ltd. announced today the upcoming release of the DZ-D100 DERMOCAMERA that allows close-up shots with the lens directly touching the skin as well as ordinary shots, all using a single camera. The new product was created based on...

at 22:10
Personalis, Inc. , a leader in advanced genomics for population sequencing and cancer, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at a price to the public of $38.00 per...

at 21:59
New England College of Optometry (NECO) announced today the receipt of a grant from the The Coca-Cola Foundation, the philanthropic arm of The Coca-Cola Company, that will fund a new diversity and inclusion scholarship.  Beatriz Perez, Chair and...

at 20:44
HealthCor Catalio Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, today announced the pricing of its upsized initial public offering of...

at 20:00
Scopus BioPharma Inc. today announced the pricing of a $9 million follow-on public offering.  The offering consists of 1,000,000 shares of common stock at a public offering price of $9.00 per share.  The company has granted the underwriters a 45-day...

News published on 30 november 2020 at 11:01 and distributed by: